Yoichi Ozawa

Eisai Co Ltd

H指数:15

被引数:2,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium (vol 4, pg 1881, 2024)

Cancer Research Communications

IF0

2025-11-010

Eng, Jason W. -L.; Kato, Yu; Adachi, Yusuke; Swaminathan, Bhairavi; Naiche, L. A.; Vadakath, Rahul; Sakamoto, Yoshimasa; Nakazawa, Youya; Tachino, Sho; Ito, Ken; Abe, Takanori; Minoshima, Yukinori; Hoshino-Negishi, Kana; Ogasawara, Hideaki; Kawakatsu, Tomomi; Nishimura, Miyuki; Katayama, Masahiko; Shimizu, Masashi; Tahara, Kazuhiro; Sato, Toshitaka; Suzuki, Katsuhisa; Agarwala, Kishan; Iwata, Masao; Nomoto, Kenichi; Ozawa, Yoichi; Imai, Toshio; Funahashi, Yasuhiro; Matsui, Junji; Kitajewski, Jan

Single-cell RNA-sequencing analysis of tumor endothelial cells reveals suppression of specific endothelial subtypes by the combination treatment of Wnt/ ß-catenin signaling modulator E7386 plus lenvatinib

CANCER RESEARCH

IF16.6

2024-03-220

PRE

The effect of lenvatinib in combination with chemotherapy plus immune checkpoint inhibitors on tumor microenvironments in the mouse syngeneic tumor model

CANCER RESEARCH

IF16.6

2023-04-040

PRE

E7386, a selective inhibitor of the interaction between β-catenin and CREB-binding protein (CBP), enhances antitumor activity in combination with lenvatinib (LEN), and LEN + anti-PD-1 antibody in a preclinical tumor model

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-01-2410

OAAI

The characterization of tumors associated with the antitumor activity of lenvatinib plus anti-PD-1 antibody combination therapy in a mouse syngeneic model panel

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling

CANCER RESEARCH

IF16.6

2021-02-1537

Yamada, Kazuhiko; Hori, Yusaku; Inoue, Satoshi; Yamamoto, Yuji; Iso, Kentaro; Kamiyama, Hiroshi; Yamaguchi, Atsumi; Kimura, Takayuki; Uesugi, Mai; Ito, Junichi; Matsuki, Masahiro; Nakamoto, Kazutaka; Harada, Hitoshi; Yoneda, Naoki; Takemura, Atsushi; Kushida, Ikuo; Wakayama, Naomi; Kubara, Kenji; Kato, Yu; Semba, Taro; Yokoi, Akira; Matsukura, Masayuki; Odagami, Takenao; Iwata, Masao; Tsuruoka, Akihiko; Uenaka, Toshimitsu; Matsui, Junji; Matsushima, Tomohiro; Nomoto, Kenichi; Kouji, Hiroyuki; Owa, Takashi; Funahashi, Yasuhiro; Ozawa, Yoichi

Inhibition of FGFR signaling by lenvatinib activates tumor interferon gamma signaling pathway and potentiates antitumor activity of anti-PD-1 antibody

CANCER RESEARCH

IF16.6

2020-08-150

PRE

A possible relationship between gene mutation profiles and activity of E7386 in in vitro models of colorectal cancer organoids

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Antitumor activity of eribulin in combination with anti-PD1 antibody in a mouse syngeneic breast cancer model

CANCER RESEARCH